Checkout process - Register | Global Market Insights

Report License

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Order Review

Kidney Cancer Drugs Market – By Cancer Type (Renal Cell, Transitional Cell, Wilms Tumor), Therapy (Immunotherapy, Chemotherapy), Drug Class (Mabs, Angiogenesis & mTOR Inhibitors), Route of Administration, Distribution Channel & Global Forecast (2024 – 2032)

Report ID: GMI10004

Selected License: $8,350

Discount: $2,505

Order Total: $5,845